Literature DB >> 18398242

Malignancy: an unrecognized risk factor for coronary stent thrombosis?

Alex R Hobson1, Daniel B McKenzie, Vijayalakshmi Kunadian, Ian Purcell, Azfar Zaman, Keith D Dawkins, Nick Curzen.   

Abstract

Stent thrombosis is a potentially catastrophic complication of coronary artery stenting. There have been particular concerns about the incidence of stent thrombosis following insertion of drug-eluting stents. We report a series of cases in which stent thrombosis occurred in association with malignancy and describe the potential mechanisms behind such an association. We speculate that this association merits further investigation as it raises the possibility that known malignancy may be a risk factor for stent thrombosis and that unexplained stent thrombosis, particularly if recurrent, should stimulate a search for occult malignancy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398242

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  3 in total

1.  Treatment of vertebral artery origin stenosis with a Pharos stent device: a single center experience.

Authors:  E Broussalis; A B Kunz; G Luthringshausen; S Klein; M R McCoy; E Trinka; M Killer-Oberpfalzer
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

2.  Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance.

Authors:  Aaron B Baker; William J Gibson; Vijaya B Kolachalama; Mordechai Golomb; Laura Indolfi; Christopher Spruell; Eyal Zcharia; Israel Vlodavsky; Elazer R Edelman
Journal:  J Am Coll Cardiol       Date:  2012-04-24       Impact factor: 24.094

3.  Early renal arterial stent thrombosis associated with the JAK2 V617F mutation.

Authors:  Piotr Tabaczewski; Suhasini Nadesan; Seah H Lim
Journal:  Leuk Res       Date:  2008-07-18       Impact factor: 3.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.